Molecular precursor lesions in oesophageal cancer

Cancer Surveys

Volumn 32, Issue , 1998, Pages 53-68

  Montesano, R ^a   Hainaut, P ^a  

^a INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR; PROTEIN P53; RETINOBLASTOMA PROTEIN;

ADENOCARCINOMA; CARCINOGENESIS; CHROMOSOME LOSS; CLONE; ESOPHAGUS CANCER; GENE MUTATION; HUMAN; MULTIPLE CANCER; PRIORITY JOURNAL; REVIEW; SMOKING; SQUAMOUS CELL CARCINOMA; TUMOR SUPPRESSOR GENE;

ADENINE; ADENOCARCINOMA; BASE PAIRING; CARCINOMA, SQUAMOUS CELL; CLONE CELLS; DISEASE PROGRESSION; ESOPHAGEAL NEOPLASMS; GENES, P53; GUANINE; HUMANS; MUTATION; PRECANCEROUS CONDITIONS; SURVIVAL RATE; THYMINE;

EID: 0031684137     PISSN: 02612429     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (77)

1. Aas T, Borresen AL, Geisler S et al (1996) Specific P53 mutations are associated with de novo resistance to doxorubicin in breast cancer patients. Nature Medicine 2 811-814
2. Aoki T, Mori T, Du X, Nisihira T, Matsubara T and Nakamura Y (1994) Allelotype study of esophageal carcinoma. Genes, Chromosomes and Cancer 10 177-182
3. Barnas C, Martel-Planche G, Furukawa Y, Hollstein M, Montesano R and Hainaut P (1997) Inactivation of the p53 protein in cell lines derived from human esophageal cancers. International Journal of Cancer 71 79-87
4. Barrett MT, Galipeau PC, Sanchez CA, Emond MJ and Reid BJ (1996a) Determination of the frequency of loss of heterozygosity in esophageal adenocarcinoma by cell sorting, whole genome amplification and microsatellite polymorphisms. Oncogene 12 1873-1878
5. Barrett MT, Sanchez CA, Galipeau PC, Neshat K, Emond M and Reid BJ (1996b) Allelic loss of 9p21 and mutation of the CDKN2/p16 gene develop as early lesions during neoplastic progression in Barrett's esophagus. Oncogene 13 1867-1873
6. Barrett MT, Schutte M, Kern SE and Reid BJ (1996c) Allelic loss and mutational analysis of the DPC4 gene in esophageal adenocarcinoma. Cancer Research 56 4351-4353
7. Baylin SB (1997) Tying it all together: epigenetics, genetics, cell cycle, and cancer. Science 277 1948-1949
8. Bennett WP, Hollstein MC, Metcalf RA et al (1992) p53 mutation and protein accumulation during multistage human esophageal carcinogenesis. Cancer Research 52 6092-6097
9. Berrino F, Sant M, Verdecchia A, Capacaccia R, Hakulinen T and Esteve J (1995) Survival of Cancer Patients in Europe - The Eurocare Study, pp 1-463, IARC, Lyon
10. Borresen-Dale A-L, Lothe RA, Meling GI, Hainaut P, Rognum TO and Skovlund E (1997) TP53 and long term prognosis in colorectal cancer; mutations in the L3 Zn-binding domain predict poor survival. Clinical Cancer Research 4 203-210
11. Bosset JF, Gignoux M, Triboulet JP et al (1997) Chemoradiotherapy followed by surgery compared with surgery alone in squamous-cell cancer of the esophagus. New England Journal of Medicine 337 161-167
12. Brennan JA, Boyle JO, Koch WM et al (1995a) Association between cigarette smoking and mutation of the p53 gene in squamous-cell carcinoma of the head and neck. New England Journal of Medicine 332 712-717
13. Brennan JA, Mao L, Hruban RH et al (1995b) Molecular assessment of histopathological staging in squamous-cell carcinoma of the head and neck. New England Journal of Medicine 332 429-435
14. Caldas C and Ponder BA (1997) Cancer genes and molecular oncology in the clinic. Lancet 349 (Supplement 2) SII16-SII18
15. Casson AG, Mukhopadhyay T, Cleary KR, Ro JY, Levin B and Roth JA (1991) p53 gene mutations in Barrett's epithelium and esophageal cancer. Cancer Research 51 4495-4499
16. Chanvitan A, Nekarda H and Casson AG (1995) Prognostic value of DNA index, S-phase fraction and p53 protein accumulation after surgical resection of esophageal squamous-cell carcinomas in Thailand. International Journal of Cancer 63 381-386
17. Chuang LS-H, Ian HI, Koh TW, Ng H-H, Xu G and Li BFL (1997) Human DNA-(cytosine-5) methyltransferase-PCNA complex as a target for p21WAF1. Science 277 1996-2000
18. Chung KY, Mukhopadhyay T, Kim J et al (1993) Discordant p53 gene mutations in primary head and neck cancers and corresponding second primary cancers of the upper aerodigestive tract. Cancer Research 53 1676-1683
19. Correa P (1982) Precursors of gastric and esophageal cancer. Cancer 50 2554-2565
20. Correa P (1996) Morphology and natural history of cancer precursors, In: Schottenfield D and Fraumeni JF (eds). Cancer Epidemiology and Prevention, 2nd ed, pp 45-64, Oxford University Press, Oxford
21. Day NE and Varghese C (1994) Oesophageal cancer. Cancer Surveys 19/20 43-54
22. Esteve A, Martel Planche G, Sylla BS, Hollstein M, Hainaut P and Montesano R (1996) Low frequency of p16/CDKN2 gene mutations in esophageal carcinomas. International Journal of Cancer 66 301-304
23. Fennerty MB (1997) Barrett's esophagus: what do we really know about this disease? American Journal of Gastroenterology 92 1-3
24. Field JK, Spandidos DA, Malliri A, Gosney JR, Yiagnisis M and Stell PM (1991) Elevated P53 expression correlates with a history of heavy smoking in squamous cell carcinoma of the head and neck. British Journal of Cancer 64 573-577
25. Foulds L (1975) Neoplastic Development, Academic Press, New York
26. Galipeau PC, Cowan DS, Sanchez CA et al (1996) 17p (p53) allelic losses, 4N (G(2)/tetraploid) populations, and progression to aneuploidy in Barrett's esophagus. Proceedings of the National Academy of Sciences of the USA 93 7081-7084
27. Gammon MD, Schoenberg JB, Ahsan H et al (1997) Tobacco, alcohol, and socioeconomic status and adenocarcinomas of the esophagus and gastric cardia. Journal of the National Cancer Institute 89 1277-1284
28. Gao H, Wang LD, Zhou Q, Hong JY, Huang TY and Yang CS (1994) p53 tumor suppressor gene mutation in early esophageal precancerous lesions and carcinoma among high-risk populations in Henan, China. Cancer Research 54 4342-4346
29. Gleeson CM, Sloan JM, McGuigan JA, Ritchie AJ, Weber JL and Russell SE (1996) Ubiquitous somatic alterations at microsatellite alleles occur infrequently in Barrett's-associated esophageal adenocarcinoma. Cancer Research 56 259-263
30. Goh HS, Yao J and Smith DR (1995) p53 point mutation and survival in colorectal cancer patients. Cancer Research 55 5217-5221
31. Greenblatt MS, Bennett WP, Hollstein M and Harris CC (1994) Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Research 54 4855-4878
32. Hainaut P, Soussi T, Shomer B et al (1997) Database of p53 gene somatic mutations in human tumors and cell lines: updated compilation and future prospects. Nucleic Acids Research 25 151-157
33. Hainaut P, Hernandez T, Robinson A et al (1998) IARC database of p53 gene mutations in human tumors and cell lines: updated compilation, revised formats and new visualisation tools. Nucleic Acids Research 26 205-213
34. Hammoud ZT, Kaleem Z, Cooper JD, Sundaresan RS, Patterson GA and Goodfellow PJ (1996) Allelotype analysis of esophageal adenocarcinomas: evidence for the involvement of sequences on the long arm of chromosome 4. Cancer Research 56 4499-4502
35. Harris CC (1996) The 1995 Walter Hubert Lecture - molecular epidemiology of human cancer: insights from the mutational analysis of the p53 tumour suppressor gene. British journal of Cancer 73 261-269
36. Hayashi K, Metzger R, Salonga D et al (1997) High frequency of simultaneous loss of p16 and p16beta gene expression in squamous cell carcinoma of the esophagus but not in adenocarcinoma of the esophagus or stomach. Oncogene 15 1481-1488
37. Hayashi T, Sagawa H, Kobuke K, Fujii K, Yokozaki H and Tahara E (1996) Molecular-pathological analysis of a patient with three synchronous squamous cell carcinomas in the aerodigestive tract. Japanese Journal of Clinical Oncology 26 368-373
38. He D, Zhang D-E, Lam K-Y et al (1997) Prevalence of HPV infection in esophageal squamous cell carcinoma in Chinese patients and its relationship to the p53 gene mutation. International Journal of Cancer 72 959-964
39. Hollstein MC, Metcalf RA, Welsh JA, Montesano R and Harris CC (1990) Frequent mutation of the p53 gene in human esophageal cancer. Proceedings of the National Academy of Sciences of the USA 87 9958-9961
40. Hollstein M, Shomer B, Greenblatt M et al (1996) Somatic point mutations in the p53 gene of human tumors and cell lines: update compilation. Nucleic Acids Research 24 141-146
41. Howley PM (1994) Viral carcinogenesis, In: Mendelsohn J and Howley PM (eds). Molecular Biology of Cancer, pp 38-58, WB Saunders, Philadelphia, Pennsylvania
42. Igaki H, Sasaki H, Kishi T et al (1994) Highly frequent homozygous deletion of the p16 gene in esophageal cancer cell lines. Biochemical and Biophysical Research Communications 203 1090-1095
43. Jiang W, Zhang Y-J, Kahn SM et al (1993) Altered expression of the cyclin Dl and retinoblastoma genes in human esophageal cancer. Proceedings of the National Academy of Sciences of the USA 90 9026-9030
44. Johns BAE (1952) Developmental changes in the oesophageal epithelium in man. Journal of Anatomy 86 431-442
45. Jones PA, Buckley JD, Henderson BE, Ross RK and Pike MC (1991) From gene to carcinogen: a rapidly evolving field in molecular epidemiology. Cancer Research 51 3617-3620
46. Kim R, Weissfeld JL, Reynolds JC and Kuller LH (1997) Etiology of Barrett's metaplasia and esophageal adenocarcinoma. Cancer Epidemiology Biomarkers and Prevention 6 369-377
47. Kitahara K, Yasui W, Yokozaki H et al (1997) Expression of cyclin D1, CDK4 and p27KIPl is associated with the pl6MTS1 gene status in human esophageal carcinoma lines. Journal of Experimental Therapeutics and Oncology 1 7-12
48. Levine AJ (1997) p53, the cellular gatekeeper for growth and division. Cell 88 323-331
49. Maesawa C, Tamura G, Nishizuka S et al (1997) MAD-related genes on 18q21.1, Smad2 and Smad4, are altered infrequently in esophageal squamous cell carcinoma. Japanese Journal of Cancer Research 88 340-343
50. Mandard AM, Marnay J, Lebeau C, Benard S and Mandard JC (1997) Expression of p53 in oesophageal squamous epithelium from surgical specimens resected for squamous cell carcinoma of the oesophagus, with special reference to uninvolved mucosa. Journal of Pathology 181 153-157
51. Miura K, Okita K, Furukawa Y, Matsuno S and Nakamura Y (1995) Deletion mapping in squamous cell carcinomas of the esophagus defines a region containing a tumor suppressor gene within a 4-centimorgan interval of the distal long arm of chromosome 9. Cancer Research 55 1828-1830
52. Montesano R, Hollstein M and Hainaut P (1996) Genetic alterations in esophageal cancer and their relevance to etiology and pathogenesis: a review. International Journal of Cancer 69 225-235
53. Montesano R, Hainaut P and Wild CP (1997) Hepatocellular carcinoma: from gene to public health. Journal of the National Cancer Institute 89 1844-1851
54. Mori T, Yanagisawa A, Kato Y et al (1994) Accumulation of genetic alterations during esophageal carcinogenesis. Human Molecular Genetics 3 1969-1971
55. Muñoz N (1997) Le dépistage du cancer de l'oesophage est-il réalisable? Semaines des Hôpitaux de Paris 73 633-635
56. Muñoz N and Day NE (1997) Esophageal cancer, In: Schottenfeld D and Fraumeni JF (eds). Cancer Epidemiology and Prevention, 2nd ed, pp 681-706, Oxford University Press, Oxford
57. Muzeau F, Flejou JF, Belghiti J, Thomas G and Hamelin R (1997a) Infrequent microsatellite instability in oesophageal cancers. British Journal of Cancer 75 1336-1339
58. Muzeau F, Flejou JF, Thomas G and Hamelin R (1997b) Loss of heterozygosity on chromosome 9 and p16 (MTS1, CDKN2) gene mutations in esophageal cancers. International Journal of Cancer 72 27-30
59. Nees M, Homann N, Discher H et al (1993) Expression of mutated p53 occurs in tumor-distant epithelia of head and neck cancer patients: a possible molecular basis for the development of multiple tumors. Cancer Research 53 4189-4196
60. Neshat K, Sanchez CA, Galipeau PC, Levine DS and Reid BJ (1994) Barrett's esophagus: the biology of neoplastic progression. Gastroenterology and Clinical Biology 18 D71-76
61. Nowell PC (1976) The clonal evolution of tumor cell populations. Science 194 23-28
62. Ory K, Legros Y, Auguin C and Soussi T (1994) Analysis of the most representative tumour- derived p53 mutants reveals that changes in protein conformation are not correlated with loss of transactivation or inhibition of cell proliferation. EMBO Journal 13 3496-3504
63. Sarbia M, Porschen R, Borchard F, Horstmann O, Willers R and Gabbert HE (1994) p53 protein expression and prognosis in squamous cell carcinoma of the esophagus. Cancer 74 2218-2223
64. Shen JC, Zingg JM, Yang AS, Schmutte C and Jones PA (1995) A mutant HpaII methyltransferase functions as a mutator enzyme. Nucleic Acids Research 23 4275-4282
65. Shin DM, Kim J, Ro JY et al (1994) Activation of p53 gene expression in premalignant lesions during head and neck tumorigenesis. Cancer Research 54 321-326
66. Slaughter DP, Southwick HW and Smejkal W (1953) Field cancerization in oral stratified squamous epithelium. Cancer 6 963-968
67. Spechler SJ (1997) Esophageal columnar metaplasia (Barrett's esophagus). Gastrointestinal Endoscopy Clinics of North America 7 1-18
68. Stone S, Jiang P, Dayananth P et al (1995) Complex structure and regulation of the P16 (MTS1) locus. Cancer Research 55 2988-2994
69. Tanaka H, Shimada Y, Imamura M, Shibagaki I and Ishizaki K (1997) Multiple types of aberrations in the p16 (INK4a) and the p15 (INK4b) genes in 30 esophageal squamous-cell-carcinoma cell lines. International Journal of Cancer 70 437-442
70. Wang DY, Xiang YY, Tanaka M et al (1994) High prevalence of p53 protein overexpression in patients with esophageal cancer in Linxian, China and its relationship to progression and prognosis. Cancer 74 3089-3096
71. Wang LD, Shi ST, Zhou Q et al (1994) Changes in p53 and cyclin D1 protein levels and cell proliferation in different stages of human esophageal and gastric-cardia carcinogenesis. International Journal of Cancer 59 514-519
72. Wang L, Li W, Wang X et al (1996) Genetic alterations on chromosomes 3 and 9 of esophageal cancer tissues from China. Oncogene 12 699-703
73. Waridel F, Estreicher A, Bron L et al (1997) Field cancerisation and polyclonal p53 mutation in the upper aerodigestive tract. Oncogene 14 163-169
74. World Health Organization (1997) The World Health Report 1997, Conquering Suffering, Enriching Humanity, World Health Organization, Geneva
75. Yang AS, Shen JC, Zingg JM, Mi S and Jones PA (1995) HhaI and HpaII DNA methyltransferases bind DNA mismatches, methylate uracil and block DNA repair. Nucleic Acids Research 23 1380-1387
76. Zhang ZF, Kurtz RC and Marshall JR (1997) Cigarette smoking and esophageal and gastric cardia adenocarcinoma. Journal of the National Cancer Institute 89 1247-1249
77. Zhuang Z, Vortmeyer AO, Mark EJ et al (1996) Barrett's esophagus: metaplastic cells with loss of heterozygosity at the APC gene locus are clonal precursors to invasive adenocarcinoma. Cancer Research 56 1961-1964